AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laaksonen, D. E
Right arrow Articles by Mykkänen, H. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laaksonen, D. E
Right arrow Articles by Mykkänen, H. M
Agricola
Right arrow Articles by Laaksonen, D. E
Right arrow Articles by Mykkänen, H. M
American Journal of Clinical Nutrition, Vol. 82, No. 6, 1218-1227, December 2005
© 2005 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome1,2,3

David E Laaksonen, Leena K Toppinen, Katri S Juntunen, Karin Autio, Kirsi-Helena Liukkonen, Kaisa S Poutanen, Leo Niskanen and Hannu M Mykkänen

1 From the Departments of Medicine (DEL and LN), Physiology (DEL), and Clinical Nutrition (LKT, KSJ, and HMM), University of Kuopio, Kuopio, Finland; the Kuopio Social Welfare and Health Center, Kuopio, Finland (KSJ); and VTT Biotechnology, Espoo, Finland (KA, K-HL, and KSP)

Background: The metabolic syndrome markedly increases the risk of type 2 diabetes and cardiovascular disease, but the influence of dietary modification on insulin and glucose metabolism independent of weight loss is still poorly understood.

Objective: Our aim was to test whether carbohydrate dietary modifications improve insulin sensitivity and secretion and glucose tolerance in overweight or obese persons with the metabolic syndrome, even in the absence of weight loss.

Design: We assessed the effect of carbohydrate modification on insulin and glucose metabolism in 72 overweight or obese men and women with the metabolic syndrome, as determined according to the National Cholesterol Education Program criteria. The subjects were randomly assigned to 12-wk diets in which either rye bread and pasta or oat and wheat bread and potato were the main carbohydrate sources (34% and 37% of energy intake, respectively).

Results: Body weight did not significantly change in either group during the trial. No significant difference was observed in the changes in fasting glucose and insulin concentrations or in glucose and insulin areas under the curve between the groups during a 2-h oral-glucose-tolerance test. The insulinogenic index (an index of early insulin secretion) increased more in the rye bread and pasta group than in the oat and wheat bread and potato group (33.2% compared with 5.5%; P = 0.026). In the combined groups, an enhanced insulinogenic index was associated with improved glucose tolerance, whereas weight gain worsened glucose tolerance. Moreover, even modest weight gains abolished the relative improvement in the insulinogenic index in the rye bread and pasta group compared with the oat and wheat bread and potato group (P for the interaction between weight change and group = 0.019).

Conclusions: Rye bread and pasta-based carbohydrate modification enhances early insulin secretion in persons with the metabolic syndrome, which may lower the risk of deteriorating glucose tolerance and development of type 2 diabetes.

Key Words: Rye • oat • wheat • insulin secretion • glucose tolerance • metabolic syndrome • randomized controlled trial




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
P. Kallio, M. Kolehmainen, D. E Laaksonen, L. Pulkkinen, M. Atalay, H. Mykkanen, M. Uusitupa, K. Poutanen, and L. Niskanen
Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1497 - 1503.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. M. Wolever, A. L Gibbs, C. Mehling, J.-L. Chiasson, P. W Connelly, R. G Josse, L. A Leiter, P. Maheux, R. Rabasa-Lhoret, N W. Rodger, et al.
The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein
Am. J. Clinical Nutrition, January 1, 2008; 87(1): 114 - 125.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al.
Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes
Physiol Genomics, October 19, 2007; 31(2): 264 - 272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Mosdol, D. R Witte, G. Frost, M. G Marmot, and E. J Brunner
Dietary glycemic index and glycemic load are associated with high-density-lipoprotein cholesterol at baseline but not with increased risk of diabetes in the Whitehall II study
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 988 - 994.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. M Zivkovic, J B. German, and A. J Sanyal
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Kallio, M. Kolehmainen, D. E Laaksonen, J. Kekalainen, T. Salopuro, K. Sivenius, L. Pulkkinen, H. M Mykkanen, L. Niskanen, M. Uusitupa, et al.
Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1417 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Sharma, I. C. Okere, M. K. Duda, D. J. Chess, K. M. O'Shea, and W. C. Stanley
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy
Cardiovasc Res, January 15, 2007; 73(2): 257 - 268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Hallikainen, L. Toppinen, H. Mykkanen, J. J Agren, D. E Laaksonen, T. A Miettinen, L. Niskanen, K. S Poutanen, and H. Gylling
Interaction between cholesterol and glucose metabolism during dietary carbohydrate modification in subjects with the metabolic syndrome
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1385 - 1392.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition